نتائج البحث - Hong‐Sik Kim

  • يعرض 1 - 6 نتائج من 6
تنقيح النتائج
  1. 1
    Rice-Based Gluten-Free Foods and Technologies: A Review

    Rice-Based Gluten-Free Foods and Technologies: A Review حسب Ji Young Park, Hong‐Sik Kim

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    The Effect of Anxiety, Depression, and Optimism on Postoperative Satisfaction and Clinical Outcomes in Lumbar Spinal Stenosis and Degenerative Spondylolisthesis Patients: Cohort Study

    The Effect of Anxiety, Depression, and Optimism on Postoperative Satisfaction and Clinical Outcomes in Lumbar Spinal Stenosis and Degenerative Spondylolisthesis Patients: Cohort St... حسب Jaewon Lee, Hong‐Sik Kim, Kyu-Dong Shim, Ye‐Soo Park

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    The Effect of Zoledronic Acid on the Volume of the Fusion-Mass in Lumbar Spinal Fusion

    The Effect of Zoledronic Acid on the Volume of the Fusion-Mass in Lumbar Spinal Fusion حسب Ye‐Soo Park, Hong-Sik Kim, Seung-Wook Baek, Dong-Yi Kong, Jeong Ah Ryu

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Peptic and Tryptic Hydrolysis of Native and Heated Whey Protein to Reduce Its Antigenicity

    Peptic and Tryptic Hydrolysis of Native and Heated Whey Protein to Reduce Its Antigenicity حسب S.B. Kim, Kwang-Seok Ki, M. A. Khan, W.S. Lee, H.J. Lee, Byeong Seok Ahn, Hong‐Sik Kim

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Enzymatic Hydrolysis of Heated Whey: Iron-Binding Ability of Peptides and Antigenic Protein Fractions

    Enzymatic Hydrolysis of Heated Whey: Iron-Binding Ability of Peptides and Antigenic Protein Fractions حسب S.B. Kim, Il Seong Seo, M. A. Khan, Kwang-Seok Ki, W.S. Lee, H.J. Lee, H.S. Shin, Hong‐Sik Kim

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real‐world data (KCSG LU20‐11)

    Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after... حسب Hong-Sik Kim, Dong‐Wan Kim, Miso Kim, Youngjoo Lee, Hee Kyung Ahn, Jang Ho Cho, Il Hwan Kim, Yun‐Gyoo Lee, Seong Hoon Shin, Song Ee Park, Ji Yoon Jung, Eun Joo Kang, Myung‐Ju Ahn

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: